1. Home
  2. DNUT vs RCKT Comparison

DNUT vs RCKT Comparison

Compare DNUT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNUT
  • RCKT
  • Stock Information
  • Founded
  • DNUT 1937
  • RCKT 1999
  • Country
  • DNUT United States
  • RCKT United States
  • Employees
  • DNUT N/A
  • RCKT N/A
  • Industry
  • DNUT Food Chains
  • RCKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • DNUT Consumer Staples
  • RCKT Health Care
  • Exchange
  • DNUT Nasdaq
  • RCKT Nasdaq
  • Market Cap
  • DNUT 505.6M
  • RCKT 326.4M
  • IPO Year
  • DNUT 2021
  • RCKT N/A
  • Fundamental
  • Price
  • DNUT $3.32
  • RCKT $2.90
  • Analyst Decision
  • DNUT Buy
  • RCKT Buy
  • Analyst Count
  • DNUT 8
  • RCKT 13
  • Target Price
  • DNUT $10.23
  • RCKT $18.50
  • AVG Volume (30 Days)
  • DNUT 3.9M
  • RCKT 4.3M
  • Earning Date
  • DNUT 08-07-2025
  • RCKT 08-04-2025
  • Dividend Yield
  • DNUT 4.22%
  • RCKT N/A
  • EPS Growth
  • DNUT N/A
  • RCKT N/A
  • EPS
  • DNUT N/A
  • RCKT N/A
  • Revenue
  • DNUT $1,597,883,000.00
  • RCKT N/A
  • Revenue This Year
  • DNUT N/A
  • RCKT N/A
  • Revenue Next Year
  • DNUT $2.80
  • RCKT N/A
  • P/E Ratio
  • DNUT N/A
  • RCKT N/A
  • Revenue Growth
  • DNUT N/A
  • RCKT N/A
  • 52 Week Low
  • DNUT $2.50
  • RCKT $2.19
  • 52 Week High
  • DNUT $12.68
  • RCKT $26.98
  • Technical
  • Relative Strength Index (RSI)
  • DNUT 61.12
  • RCKT 41.69
  • Support Level
  • DNUT $2.50
  • RCKT $2.40
  • Resistance Level
  • DNUT $2.72
  • RCKT $2.70
  • Average True Range (ATR)
  • DNUT 0.18
  • RCKT 0.21
  • MACD
  • DNUT 0.12
  • RCKT 0.15
  • Stochastic Oscillator
  • DNUT 83.67
  • RCKT 73.53

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: